TABLE 1.
Author (yr) | Location | Pathogen | No. of results | Setting | Age range | Self-swab site | HCW swab site | Test | QUADAS score |
---|---|---|---|---|---|---|---|---|---|
Altamirano (2020) | California, USA | SARS-CoV-2 | 30 | Clinic | ≥18 yrs | Nasal and pharyngeal | Nasal and pharyngeal | RT-PCR | 12 |
Kojima (2020) | California, USA | SARS-CoV-2 | 45 | Home | ≥18 yrs | Nasal and oral fluid (supervised, unsupervised) | NP | RT-qPCR | 12 |
Wehrhahn (2020) | Australia | SARS-CoV-2 | 236 | Testing facility | 7–81 yrs | Nasal and pharyngeal | Nasal, pharyngeal and NP | RT-PCR | 12 |
Yuan-Po Tu (2020) | Washington, USA | SARS-CoV-2 | 530 | Outpatient clinic | Not stated | Tongue, nasal, midturbinate | NP | RT-PCR | 11 |
Fragoso (1989) | New Jersey, USA | Group A Streptococcus | 98 | Clinic | 4–17 yrs | Pharyngeal | Pharyngeal | Culture | 8 |
Katz (1974) | Maryland, USA | Group A Streptococcus | 137 | Clinic | “Children” | Pharyngeal | Pharyngeal | Culture | 8 |
Murray (2015) | Minnesota, USA | Group A Streptococcus | 402 | Clinic | ≥3 yrs | Pharyngeal | Pharyngeal | RT-PCR | 12 |
Dhiman (2012) | Minnesota, USA | Influenza A and B | 72 | Emergency room | 18–92 yrs | Nasal (midturbinate) | Nasal (midturbinate) | RT-PCR | 12 |
Esposito (2010) | Italy | Influenza A and B | 203 | Emergency room | 6 mo to 5 yrs | Nasal (midturbinate) | Nasal (midturbinate) | RT-PCR | 11 |
Granados (2017) | Ontario, Canada | Influenza A and B | 459 | Home | Children and adults | Nasal (midturbinate) | Nasal (midturbinate) | RT-PCR | 11 |
Goyal (2017) | Thailand | Influenza A and B | 127 | Clinic | ≥65 yrs | Nasal | NP and nasal | RT-PCR | 11 |
Ip (2012) | Hong Kong | Influenza A and B | 196 | Home and clinic | Children and adults | Nasal and pharyngeal | Nasal and pharyngeal | RT-PCR | 10 |
Barbee (2020) | Washington, USA | C. trachomatis and N. gonorrhoeae | 258 | Clinic | Not stated | Pharyngeal | Pharyngeal | Culture | 12 |
Dangerfield (2019) | Maryland, USA | C. trachomatis and N. gonorrhoeae | 79 | Clinic | ≥18 yrs | Pharyngeal | Pharyngeal | NAAT | 12 |
Freeman (2011) | California, USA | C. trachomatis and N. gonorrhoeae | 480 | Clinic | Adults | Pharyngeal | Pharyngeal | NAAT | 10 |
Akmatov (2012) | Germany | Respiratory pathogens | 82 | Research institute | 18–69 yrs | Nasal (anterior nares) | Nasal | Multiplex PCR | 10 |
Larios (2011) | Ontario, Canada | Respiratory pathogens | 60 | Not stated | 23–59 yrs | Nasal (midturbinate) | NP | RT-PCR | 10 |
Vargas (2016) | New York, USA | Respiratory pathogens | 30 | Home | Children and adults | Nasal | Nasal | Multiplex RT-PCR | 12 |
Lautenbach (2009) | Pennsylvania, USA | Staphylococcus aureus | 56 | Hospital (inpatients) | Children and adults | Nasal and pharyngeal | Nasal and pharyngeal | Culture | 10 |
van Cleef (2012) | Netherlands | Staphylococcus aureus | 105 | Hospital (staff) | Adults | Nasal and pharyngeal | Nasal and pharyngeal | Culture | 11 |
HCW, health care worker; NAAT, nucleic acid amplification test; NP, nasopharyngeal; RT-PCR, reverse transcription PCR; qPCR, quantitative PCR; SARS-CoV-2, severe acute respiratory coronavirus 2; QUADAS, evidence-based tool for Quality Assessment of Diagnostic Accuracy Studies.